Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

Equity Insider News Commentary ? The World Economic Forum recently spotlighted five healthcare breakthroughs, and at the top of the list was artificial intelligence. From surgical precision tools to ...

CBS News CEO Wendy McMahon says she's quitting. It's the latest fallout at the network as its parent company considers ...

Regeneron bids for 23andMe for a discounted price of $256 million. The testing firm was once valued at $3.5 billion.

Coinbase, the largest cryptocurrency exchange based in the U.S., said Thursday that criminals had improperly obtained ...

According to a new market research report titled "Battery Swapping Market by Swapping Type (Manual, Semi-Automated, Fully Automated), Vehicle Type (2W, 3W, 4W, Commercial Vehicles), Service Model ...